NASDAQ:HEPA

Hepion Pharmaceuticals Stock News

etoro logo Buy HEPA
*Your capital is at risk
$0.0600
-0.0030 (-4.76%)
At Close: Jun 03, 2026
UBS Group AG cut its stake in shares of NGM Biopharmaceuticals (NYSE:NGM) by 60.5% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The
First National Study Predicts an Escalating Epidemic of Nonalcoholic Fatty Liver Disease (NAFLD)
Biotech stocks rebounded along with the broader market in the week ended June 19. The week was a busy one from the perspective of PDUFA dates, with the FDA issuing approvals...
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE